Fig. 1

Preferred Reporting Items for Systematic Reviews and Meta-analyses flow diagram of studies included in the review. ACR American College of Rheumatology, DAS28 Disease Activity Score in 28 joints, AE adverse event, SAE serious adverse event, TCZ tocilizumab, csDMARDs disease-modifying anti-rheumatic drugs